iStock-1199361165.jpg

Mass General Brigham Ventures

Investment Team

Our team combines proven investment acumen with the scientific background necessary to analyze the risks and complexities of early-stage life science investing. Our expertise encompasses the range of venture financing, biomedical research, entrepreneurship, operational management, product development, and strategic partnering. The team works closely with Mass General Brigham’s extensive network of clinical and scientific experts to source opportunities and validate them as commercially viable concepts.  

Kitterman-Roger-900x570.jpg

Roger Kitterman

Managing Partner

LinkedIn.png
Knowles-Jay.jpg

Julius Knowles

Partner

LinkedIn.png
Berke-Carl.jpg

Carl Berke, PhD

Partner

LinkedIn.png
Stacey-3-900x570.jpg

Stacey Brenner

Senior Director, Investor

Relations & Finance

LinkedIn.png
Meredith-2.jpg

Meredith Fisher, PhD

Partner

LinkedIn.png
image0.jpeg

Bhamini Vaidialingam

Venture Associate

LinkedIn.png

Entrepreneurs in residence

Pauline Ryan.jpg

Pauline Jen Ryan

Biotech Executive

Stan Nowak Censinet.jpg

Stan Nowak

Digital Health Executive

Alumni

Entrepreneurs in residence

de Graaf.png

David de Graaf

Mediar Therapeutics, Board of Directors

Fox.jpg

Barbara Fox

Tilos Therapeutics, Founding CEO
(Acquired by Merck)

Millman.jpg

Robert Millman

Ncontrol Therapeutics, Founding CEO
CoStim, Co-Founder, President
(Acquired by Novartis)

Ripple.jpg

John Ripple

Brave Bio, Board of Directors

Ellen SHeets.webp

Ellen Sheets, MD

SeQure DX, Founding CEO

B61A8620-1-copy.jpg

Bill Yelle

FireCyte Therapeutics, Founding CEO